The pros and cons of e-cigarettes
There's no cure. But the good news is that prophylaxis is possible.
Adam Scott Roberts, Senior Vice President, Group Media Director, Communications Media Inc.
Maggie Helmig, EVP, global brand lead, Ogilvy CommonHealth
Promotions and hires for manufacturers and agencies
Brian Goff, Global franchise head for hemophilia, Baxter
Sales force success in the new world of prescribing takes technology. Harris Kaplan and Ann Mayer say substituting e-sampling for rep time could be a game changer for specialty brands. Why this tactic's time is now
For rare diseases and orphan products, the future looks promising, but as Peter Saltonstall finds, significant research, educational and policy challenges remain. A view from one of the patient community's staunchest advocates
With generics firms taking aim at high-flying blockbusters, Big Pharma stalwarts in the asthma and COPD market are pinning their hopes for the future on a flurry of innovative biotech-developed assets. Noah Pines charts the rarefied air of the respiratory space
Here's a countdown of 10 risk-taking ads—five that our industry experts thought truly succeeded, followed by five that might have done better. It's our shout-out to brands that took a risk.